The historical rank and industry rank for Titan Biotech's OCF Margin % or its related term are showing as below:
BOM:524717'
s OCF Margin % Range Over the Past 10 Years
Min: 0.25 Med: 12.88 Max: 17.84
Current: 14.75
During the past 13 years, the highest OCF Margin % of Titan Biotech was 17.84%. The lowest was 0.25%. And the median was 12.88%.
BOM:524717's OCF Margin % is ranked better than 79.56% of 954
companies
in the Biotechnology industry
Industry Median: -65.71
vs BOM:524717: 14.75
Titan Biotech OCF Margin % Related Terms
Titan Biotech OCF Margin % Historical Data
* Premium members only.
The historical data trend for Titan Biotech's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524717 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, Titan Biotech's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Titan Biotech OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Titan Biotech's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Titan Biotech's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Titan Biotech (BOM:524717) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Titan Biotech and its competitors. Over the past decade, Titan Biotech's OCF Margin % has ranged from 0.25 to 17.84. According to the industry distribution chart, Titan Biotech ranks #195 out of 954 companies in the Biotechnology industry, placing it in the top 20.4%.
Is Titan Biotech's OCF Margin % too high?
Titan Biotech's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 17.84. Based on the distribution chart, Titan Biotech ranks #195 out of 954 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Titan Biotech has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Titan Biotech's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Titan Biotech ranks #195 out of 954 companies for OCF Margin %. This places Titan Biotech in the top 20% of its industry — outperforming the majority of peers. Historically, Titan Biotech's own OCF Margin % has ranged from 0.25 to 17.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Titan Biotech and its competitors. Titan Biotech's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Titan Biotech stock overvalued right now?
Based on GuruFocus' analysis, Titan Biotech (BOM:524717) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹144.30, compared to a current price of ₹389.10 — trading 169.6% above its estimated fair value. The current OCF Margin % is 0.00%. Titan Biotech's overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Titan Biotech (BOM:524717), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Titan Biotech (BOM:524717) Overvalued in 2026?
Based on GuruFocus' analysis, Titan Biotech stock appears to be overvalued.
The current stock price of ₹389.10 is trading 169.6% above its estimated GF Value™ of ₹144.30.
GuruFocus considers Titan Biotech to be Significantly Overvalued.
Key valuation signals for BOM:524717:
OCF Margin %: 0.00%
GF Value™: ₹144.30 vs. price of ₹389.10 (169.6% above fair value)
No single metric tells the full story. See the BOM:524717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters, and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The company's business activity falls within a single primary business segment, which is the business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
50GF Score
Get the complete analysis for BOM:524717
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524717 has been successfully added to your 
